This HTML5 document contains 107 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n11	http://dx.doi.org/10.1016/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q80116757

rdf:type

wikibase:Item

schema:description

2007年学术文章 vědecký článek bilimsel makale επιστημονικό άρθρο vetenskaplig artikel videnskabelig artikel udgivet 23. marts 2007 tudományos cikk scienca artikolo 2007年學術文章 scientific article published on 23 March 2007 2007年学术文章 wetenschappelijk artikel научна статия 2007年學術文章 scientific article published on 23 March 2007 2007年学术文章 im März 2007 veröffentlichter wissenschaftlicher Artikel artigo científico บทความทางวิทยาศาสตร์ 2007년 논문 2007 nî lūn-bûn artigo científico мақолаи илмӣ vitenskapelig artikkel artikel ilmiah tieteellinen artikkeli artículu científicu 2007年學術文章 articolo scientifico научная статья artikull shkencor vedecký článok научни чланак 2007年学术文章 article scientifique 2007年学术文章 2007年の論文 מאמר מדעי naučni članak artigo científico مقالة علمية نشرت في 23 مارس 2007 teaduslik artikkel bài báo khoa học vitskapeleg artikkel artykuł naukowy 2007年学术文章 article científic наукова стаття, опублікована в березні 2007 2007年學術文章 научни чланак ২৩ মার্চ ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 23 March 2007 სამეცნიერო სტატია artículo científico publicado en 2007 2007年學術文章 artikulong pang-agham articol științific article scientific

p:P577

wds:Q80116757-7DD1BAC3-3A4A-413B-9C2C-A54790939CB5

wdt:P577

2007-03-23T00:00:00Z

p:P407

wds:Q80116757-6E2257DC-F014-4307-8C52-6F9B38851E2E

wdt:P407

wd:Q1860

p:P2093

wds:Q80116757-7DD97863-E990-4E84-B020-8E001E7CE54C wds:Q80116757-959D7BA5-9149-4443-B5F2-C13877419640 wds:Q80116757-134BCC65-1D8A-4C15-ABD7-9FF680A35AA2 wds:Q80116757-2FB9FF5A-F9BE-4168-A9A4-8BECB8AD9A3B wds:Q80116757-37B6CDE1-DEC3-40D7-97DA-F1846DE52E4D wds:Q80116757-F816F5F2-A9E7-4FC9-BB42-9275FF349682 wds:Q80116757-D13AFFD9-E665-4B70-892B-61308BA2E9B0 wds:Q80116757-68CC6670-F8CA-4117-907B-87456E6B9DC6 wds:Q80116757-6A06794E-7B16-4D23-9A9E-079CD7BA70B1 wds:Q80116757-BB0EBDEE-890F-4503-A282-DFFAAF7A0C51

wdt:P2093

Kinwang Cheung Allan Wissner Xingzhi Tan Malini R Ravi Heidi L Fraser Thomas Nittoli Russell G Dushin Frank Loganzo Charles L Ingalls M Brawner Floyd

rdfs:label

Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

skos:prefLabel

Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

schema:name

Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

p:P1476

wds:Q80116757-F62F9921-CD58-4ACA-982F-6DB4CE6B815C

wdt:P1476

Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

p:P304

wds:Q80116757-C651903B-52CB-4746-A6BB-8F462A8DA947

wdt:P304

3635-3648

p:P31

wds:Q80116757-2BF2D2E7-2DC5-4589-8C54-7AE6E271467C

wdt:P31

wd:Q13442814

p:P698

wds:Q80116757-99682415-4747-496C-A68A-551B9AECFB9C

wdtn:P698

n12:17416531

wdt:P698

17416531

p:P1433

wds:Q80116757-079561C9-7A25-4A7A-8066-103D50394FBC

wdt:P1433

wd:Q2904200

p:P433

wds:Q80116757-131A709E-DE9A-423E-A9E3-B30662F7CD0B

p:P478

wds:Q80116757-646EF554-9F3C-4B58-8116-8200280C99D1

wdt:P433

11

wdt:P478

15

p:P356

wds:Q80116757-3ECFE401-D3B8-4929-870A-9B326A1652A1

wdtn:P356

n11:J.BMC.2007.03.055

wdt:P356

10.1016/J.BMC.2007.03.055